Which of the following is NOT a feature of G-6PD deficiency?
Autoimmune gastritis is associated with a deficiency of which vitamin?
Hypercoagulability due to a defective factor V gene is known as which of the following?
Gall stones in hemolytic anaemia are -
Which of the following is the MOST characteristic feature of Hemolytic Uremic Syndrome (HUS)?
Maximum life of transfused RBCs is
First line investigation for deep venous thrombosis is -
What is used for exchange blood transfusion?
Which of the following does not cause intravascular hemolysis?
Mentzer index more than 13 suggests a diagnosis of
Explanation: ***Membrane defect*** - **G-6PD deficiency** is primarily characterized by a deficiency in the enzyme glucose-6-phosphate dehydrogenase, rather than a membrane defect [1]. - It leads to **oxidative stress** rather than issues with red blood cell membranes [1]. *Bite cells* - Bite cells are actually a result of **oxidative damage** due to G-6PD deficiency and occur during hemolytic episodes [2]. - They are formed when **macrophages** remove denatured hemoglobin from erythrocytes. *Intravascular hemolysis* - This condition often occurs in G-6PD deficiency due to oxidative stress leading to the destruction of red blood cells, particularly during crises [2]. - The hemolysis is often **acute** and triggered by infections, certain drugs, or food (like fava beans) [3]. *Oxidative stress* - Oxidative stress is a key pathological mechanism in G-6PD deficiency, causing vulnerability of red blood cells to hemolysis [1]. - It leads to **increased susceptibility** to infections and hemolytic episodes upon exposure to oxidant drugs or agent [2].
Explanation: ***B12*** - Autoimmune gastritis leads to destruction of **parietal cells** in the stomach, impairing intrinsic factor production, crucial for vitamin B12 absorption [2]. - Vitamin B12 deficiency can lead to **megaloblastic anemia** and neurological complications due to its key role in DNA synthesis and nerve function [1]. *C* - Vitamin C deficiency is associated with **scurvy**, which is unrelated to autoimmune gastritis and is not a consequence of gastric issues. - This vitamin primarily concerns skin health, collagen synthesis, and immune function, making it irrelevant in this context. *A* - Vitamin A deficiency is associated with **vision problems** and immune function, but it does not have a direct link to autoimmune gastritis. - Unlike B12, vitamin A is not specifically affected by the gastric conditions related to autoimmune processes. *D* - Vitamin D deficiency relates to **bone health** and calcium metabolism, and is not connected to the effects of autoimmune gastritis. - This vitamin's absorption primarily occurs in the intestines rather than involving gastric intrinsic factor or parietal cells.
Explanation: ***Leiden mutation*** - The **factor V Leiden mutation** leads to a hypercoagulable state by causing resistance to activated protein C, increasing the risk of venous thrombosis [1]. - It is the most common inherited cause of venous thromboembolism and directly associates with the defective factor V gene [1]. *Antiphospholipid syndrome* - This syndrome is characterized by the presence of **antiphospholipid antibodies** leading to recurrent thrombosis but is not directly related to the factor V gene. - It often presents with symptoms such as **venous and arterial thrombosis**, but its mechanism differs from that of factor V Leiden [2]. *Inducible thrombocytopenia syndrome* - This condition involves **thrombocytopenia** (low platelet count) often due to medication, which is unrelated to the hypercoagulable state from factor V mutation. - It does not involve the **factor V gene** nor lead to an increased risk of clotting as seen in the Leiden mutation. *Lisbon mutation* - The Lisbon mutation is a rare variant of factor V but is not the primary mutation associated with the hypercoagulable state in most cases. - It does not have the same wide clinical implications or prevalence as the **factor V Leiden mutation**.
Explanation: ***Pigment*** - In hemolytic anemia, the breakdown of hemoglobin increases bilirubin levels, leading to the formation of **pigment stones (bilirubin stones)** [1]. - These stones are typically small, dark, and made up of **calcium bilirubinate** due to excessive unconjugated bilirubin. *Any type* - This option is incorrect as it suggests that all types of gallstones can occur, which is not true for hemolytic anemia. - While cholesterol stones are common in general, they are not specifically associated with **hemolysis**. *Cholesterol* - Cholesterol stones are primarily associated with **bile saturation** and are not a result of hemolytic conditions. - They arise from an imbalance in bile salts and cholesterol rather than from **bilirubin metabolism**. *Mixed* - Mixed stones contain cholesterol and pigment, but they are less represented in hemolytic conditions compared to **pure pigment stones**. - Hemolytic anemia primarily leads to the formation of **pigment stones** [1], not a predominance of mixed stones.
Explanation: ### a and c - Hemolytic Uremic Syndrome (HUS) is characterized by **microangiopathic hemolytic anemia** along with **thrombocytopenia**, making this correct [1][2]. - It typically results from an **infection**, often associated with **E. coli**, particularly in children [2]. *Positive Coomb's test* - A positive Coomb's test suggests **autoimmune hemolytic anemia**, not HUS. - HUS generally presents with **negative Coomb's test**, indicating hemolysis mechanism is different from autoimmune causes. *Microangiopathic haemolytic anaemia* - While HUS does involve **microangiopathic hemolytic anemia** [2], this alone does not encompass all its characteristics necessary for diagnosis. - HUS must also include **thrombocytopenia**, which is not mentioned in this option [1]. *Thrombocytopenia* - Thrombocytopenia is indeed a feature of HUS, but presenting it alone lacks the context of the complete syndrome [1]. - HUS must also show **microangiopathic hemolytic anemia** to align with the complete clinical picture [2], which is missing here.
Explanation: ***80-100 days*** - The maximum lifespan of **transfused red blood cells (RBCs)** is reduced compared to naturally occurring RBCs in vivo. - This is due to storage conditions and the age of the donated blood, leading to a shorter survival time post-transfusion. *110-120 days* - This range typically represents the **normal lifespan of red blood cells in the human body** *in vivo*, not the effective lifespan of transfused units. - Transfused RBCs undergo various changes during storage (storage lesion) that reduce their post-transfusion survival. *60-80 days* - While closer to the actual range for transfused RBCs, this is generally considered a slightly **underestimated maximum lifespan**. - The survival of transfused RBCs can vary, but good quality units usually last longer than 80 days. *50-60 days* - This range is typically too low for the maximum lifespan of transfused RBCs, indicating either **poor quality blood products** or significantly **prolonged storage times**. - Most transfused RBCs, when properly stored and handled, will survive for a longer duration post-transfusion.
Explanation: ***Ultrasonography*** - **Duplex ultrasonography** is the preferred first-line investigation due to its **non-invasiveness**, widespread availability, and high accuracy for diagnosing DVT, especially in the proximal veins [1][2]. - It visualizes the vein and assesses compressibility, flow, and presence of thrombus, making it effective for **confirming or excluding DVT** [1][2]. *Venography* - **Venography** is an invasive procedure involving injection of contrast dye and X-rays, carrying risks of allergic reactions and kidney injury. - While considered the **gold standard** for detailed anatomical visualization, its invasiveness and risks make it a second-line or confirmatory test rather than a first-line diagnostic. *MRI* - **Magnetic Resonance Imaging (MRI)** is highly sensitive and specific for DVT, particularly for pelvic or atypical thrombi. - However, its **high cost**, limited availability, and longer acquisition time usually reserve it for cases where ultrasound is inconclusive or technically difficult. *Nuclear imaging* - **Nuclear imaging**, such as scintigraphy, is primarily used for diagnosing **pulmonary embolism (PE)** with Ventilation-Perfusion (V/Q) scans [2]. - It is **not a standard or primary diagnostic tool** for evaluating DVT directly, as it does not visualize thrombi in the venous system.
Explanation: ***Whole blood*** - Exchange blood transfusion aims to replace a significant volume of the patient's blood with donor blood, making **whole blood** the most appropriate component. - Using whole blood helps to concurrently address **anemia** (due to red blood cells), correct **coagulopathies** (due to plasma and platelets), and remove harmful substances like bilirubin or antibodies. *EPP* - EPP likely refers to **Erythrocyte Progenitor Cells** or another experimental component not routinely used for massive blood replacement. - It does not contain the plasma or platelets necessary for comprehensive exchange transfusion. *Serum* - **Serum** is plasma from which clotting factors have been removed and primarily contains antibodies and other proteins. - It lacks red blood cells and clotting factors, making it unsuitable for an exchange transfusion that requires oxygen-carrying capacity and coagulation support. *Packed cells* - **Packed red blood cells** are primarily used to increase oxygen-carrying capacity and treat anemia. - While they are a component of whole blood, they lack plasma and platelets, which are crucial for maintaining oncotic pressure, replacing clotting factors, and diluting harmful substances during an exchange transfusion.
Explanation: ***Hereditary spherocytosis*** - It primarily causes **extravascular hemolysis** due to spleen sequestration of **abnormal erythrocytes** [2]. - Not typically associated with **intravascular hemolysis**, making it the correct choice here. *Mismatched blood transfusion* - Causes acute **intravascular hemolysis** due to **antibody-mediated destruction** of foreign red blood cells [1]. - Results in **hemoglobinuria**, high bilirubin levels, and potential **renal failure**. *Paroxysmal cold hemoglobinuria* - Induces **intravascular hemolysis** triggered by cold temperatures and **anti-P antibodies** [3]. - Characterized by **acute hemoglobinuria** upon rewarming, complicating the clinical picture [3]. *Thermal burns* - Can lead to **intravascular hemolysis** due to damage to red blood cells from extreme heat. - Associated with **massive tissue injury** and resultant hemolytic reactions in the bloodstream.
Explanation: ***Iron deficiency anemia*** - A Mentzer index of **greater than 13** (calculated as MCV/RBC count) is highly suggestive of **iron deficiency anemia**. [1] - This index helps differentiate iron deficiency from thalassemia trait in microcytic anemias, as **MCV is disproportionately low** compared to RBC count in IDA. *Thalassemia* - Thalassemia typically presents with a **Mentzer index less than 13**, meaning the MCV reduction is proportional to or less severe than the RBC count reduction. - This condition is characterized by **reduced alpha or beta globin chain synthesis**, leading to microcytic hypochromic red blood cells but often with an elevated RBC count. *Hereditary Spherocytosis* - Hereditary spherocytosis is a **normocytic or macrocytic anemia**, not typically microcytic, making the Mentzer index less relevant for its diagnosis. - It is characterized by **spherocytes** on peripheral smear and increased red cell fragility due to membrane defects. *Autoimmune Hemolytic Anemia* - Autoimmune hemolytic anemia is typically a **normocytic to macrocytic anemia** [2] with features of hemolysis, such as elevated LDH and indirect bilirubin. - While it can be severe, it is not primarily characterized by **microcytosis** and therefore the Mentzer index is not a diagnostic tool for this condition.
Anemia Evaluation and Management
Practice Questions
Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Platelet Disorders
Practice Questions
Coagulation Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Leukemias
Practice Questions
Lymphomas
Practice Questions
Multiple Myeloma and Plasma Cell Disorders
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Transfusion Medicine
Practice Questions
Hematopoietic Stem Cell Transplantation
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free